SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif. & ...
A group of researchers has provided new insight into processes shaping the human genome. They used a clone-based method to build a comprehensive, fine-scale map of structural variation in eight human ...
PALO ALTO, Calif., Jan. 5, 2005 -- Agilent Technologies Inc. (NYSE: A) today announced a breakthrough development that enables the rapid advance of microarray-based comparative genomic studies in ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression ...
Researchers at Baylor College of Medicine (BCM), Houston, Texas, have, for the first time, observed a way that DNA additions or deletions associated with a wide range of diseases are introduced in ...
Two companies will provide an end-to-end solution tailored to application services. Oxford Gene Technology (OGT) and Agilent Technologies completed a collaborative agreement giving OGT access to ...
When Baylor College of Medicine (BCM) researcher Jennifer Lee was studying the mechanisms of Pelizaeus-Merzbacher disease (PMD), she expected to find DNA additions or deletions in the wrong place on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results